COMBINATION THERAPY WITH VEDOLIZUMAB AND AN IMMUNOMODULATOR IS PREDICTIVE OF IMPROVED PERIANAL FISTULA CLOSURE IN PATIENTS WITH CROHN'S DISEASE

被引：0
|
作者：
Gold, Stephanie
Cohen-Mekelburg, Shirley A.
Schneider, Yecheskel
Bosworth, Brian P.
Steinlauf, Adam F.
Scherl, Ellen
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1876
引用
收藏
页码：S834 / S835
页数：2
相关论文
共 50 条
  • [31] DIFFERENCES IN FISTULA VOLUME PREDICT NEED FOR PERIANAL SURGERY IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE
    George, Alvin
    Elumalai, Anusha
    Abushamma, Suha
    Smith, Radhika
    Ravella, Balakrishna
    Hickman, John
    Bishop, Grace L.
    Zulfiqar, Maria
    Ludwig, Daniel R.
    Shetty, Anup S.
    Viswanath, Satish E.
    Ballard, David H.
    Deepak, Parakkal
    GASTROENTEROLOGY, 2023, 164 (06) : S666 - S667
  • [32] Surgical-based combined therapy for complex perianal fistula in Crohn's disease
    Gao, Xiang
    Zhang, Min
    Zhi, Min
    Tang, Jiang
    Huang, Wei
    Yao, Jayin
    Chen, Junrong
    Yang, Xiaobo
    Hu, Pinjin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 589 - 589
  • [33] Fistula Healing in Perianal Crohn's Disease - With or Without Anti-TNF Therapy?
    Yassin, N. A.
    Askari, A.
    Ferrari, L.
    Faiz, O.
    Warusavitarne, J.
    Phillips, R.
    Hart, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S273 - S274
  • [34] Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
    Lutz, Megan
    Caldera, Freddy
    Schroeder, Katie
    Gazis, Derek
    Crawford, Julie M.
    Long, Millie D.
    Barnes, Edward L.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (11)
  • [35] Early medical therapy and risk of subsequent perianal fistula development among paediatric patients with Crohn's disease
    Adler, J.
    Lin, C. C.
    Gadepalli, S.
    Dombkowski, K.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S412 - S413
  • [36] Adding Ciprofloxacin to Adalimumab Results in a Higher Fistula Closure Rate in Perianal Fistulizing Crohn's Disease
    Dewint, Pieter
    Hansen, Bettina E.
    Verhey, Elke
    Oldenburg, Bas
    Hommes, Daniel W.
    Pierik, Marie J.
    Ponsioen, Cyriel
    van Dullemen, Hendrik M.
    Russel, Maurice G.
    van Bodegraven, Adriaan A.
    van der Woude, Christien J.
    GASTROENTEROLOGY, 2012, 142 (05) : S212 - S212
  • [37] Efficacy of Vedolizumab With Concomitant Corticosteroid or Immunomodulator Use in Patients With Crohn's Disease From GEMINI 2
    Colombel, Jean-Frederic
    Loftus, Edward V.
    Siegel, Corey A.
    Lewis, James
    Smyth, Michael D.
    Xu, Jing
    Abhyankar, Brihad
    GASTROENTEROLOGY, 2015, 148 (04) : S277 - S277
  • [38] The challenge of fistula closure in Crohn's disease: an endoscopic technique for closure of a fistula
    Matsumoto, Satohiro
    Mashima, Hirosato
    ENDOSCOPY, 2021, 53 (02) : E55 - E57
  • [39] Risk Factors for Rescue Therapy in Crohn's Patients on Combination Therapy After Discontinuation of the Immunomodulator
    Fischer, Monika
    Campbell, Sarah C.
    Johnson, Cynthia S.
    Helper, Debra J.
    Chiorean, Michael V.
    GASTROENTEROLOGY, 2014, 146 (05) : S450 - S450
  • [40] Vedolizumab as a rescue therapy for patients with medically refractory Crohn's disease
    Crowell, K. T.
    Tinsley, A.
    Williams, E. D.
    Coates, M. D.
    Bobb, A.
    Koltun, W. A.
    Messaris, E.
    COLORECTAL DISEASE, 2018, 20 (10) : 905 - 912
12345